Third Rock Ventures, founded in 2007 and headquartered in Boston, Massachusetts, is a venture capital firm specializing in the life sciences sector. The firm focuses on discovering, launching, and building companies that aim to make a significant impact on patients’ lives by advancing transformative science and medicine.

As of 2022, Third Rock Ventures has raised over $3.4 billion across multiple funds, with its most recent fund closing at $1.1 billion in June 2022. The firm has invested in over 60 companies, including notable biotech firms such as Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals, and Flare Therapeutics.